多重血清生物标志物鉴别非存活妊娠与异位妊娠
一项嵌套病例对照研究纳入218例孕早期伴疼痛和/或出血者(宫内活胎75例、异位妊娠68例、流产75例),评估24种血清生物标志物的机器学习组合模型。分类回归树模型用PSG3、绒毛膜促性腺激素α亚基和妊娠相关血浆蛋白A预测妊娠非存活,最高敏感度93.3%、特异度98.6%;用可溶性fms样酪氨酸激酶-1、PSG3和组织因子途径抑制物2预测异位妊娠,最高敏感度98.5%、特异度95.3%。
要点
- 用PSG3、绒毛膜促性腺激素α亚基和妊娠相关血浆蛋白A可预测妊娠非存活
- 用可溶性fms样酪氨酸激酶-1、PSG3和组织因子途径抑制物2可预测妊娠位置
- 两模型同时使用时明确分类率升至72.7%,准确率95.9%
核心结论
- 来自不同生物学通路的生物标志物组合可用于对可能出现早期妊娠丢失的个体进行分类。
- 绒毛膜促性腺激素α亚基、妊娠相关血浆蛋白A和PSG3可用于预测妊娠存活,可溶性fms样酪氨酸激酶-1、组织因子途径抑制物2和PSG3可用于预测妊娠位置。
研究设计与样本
- 研究为嵌套病例对照设计,在三所大学医院开展。
- 共纳入218例孕早期伴疼痛和/或出血者:宫内活胎75例、异位妊娠68例、流产75例。
- 对同一批患者检测24种血清生物标志物,并用多种机器学习方法评估其组合。
- 结局指标为各模型预测分类与实际诊断比较,计算敏感度、特异度、阳性预测值、阴性预测值、明确分类率和准确率。
主要发现
- 用分类回归树分析、纳入3种标志物(PSG3、绒毛膜促性腺激素α亚基、妊娠相关血浆蛋白A)的模型预测妊娠非存活,最高敏感度93.3%、最高特异度98.6%。
- 上述模型中准确率最高为97.4%,其中70.2%获得分类。
- 用另一重叠的3种标志物组合(可溶性fms样酪氨酸激酶-1、PSG3、组织因子途径抑制物2)预测异位妊娠,最高敏感度98.5%、最高特异度95.3%。
- 该模型中准确率最高为94.4%,其中65.6%获得分类。
- 两模型同时使用时明确分类率升至72.7%,准确率95.9%;随机森林使用11种预测标志物时测试特征相似。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To evaluate combinations of candidate biomarkers to develop a multiplexed prediction model for identifying the viability and location of an early pregnancy. In this study, we assessed 24 biomarkers with multiple machine learning-based methodologies to assess if multiplexed biomarkers may improve the diagnosis of normal and abnormal early pregnancies. DESIGN: A nested case-control design evaluated the predictive ability and discrimination of biomarkers in patients at risk of early pregnancy failure in the first trimester to classify viability and location. SETTING: Three university hospitals. PATIENTS: A total of 218 individuals with pain and/or bleeding in early pregnancy: 75 had an ongoing intrauterine gestation; 68 had ectopic pregnancies (EPs); and 75 had miscarriages. INTERVENTIONS: Serum levels of 24 biomarkers were assessed in the same patients. Multiple machine learning-based methodologies to evaluate combinations of these top candidates to develop a multiplexed prediction model for the identification of a nonviable pregnancy (ongoing intrauterine pregnancy vs. miscarriage or EP) and an EP (EP vs. ongoing intrauterine pregnancy or miscarriage). MAIN OUTCOME MEASURES: The predicted classification using each model was compared with the actual diagnosis, and sensitivity, specificity, positive predictive value, negative predictive value, conclusive classification, and accuracy were calculated. RESULTS: Models using classification regression tree analysis using 3 (pregnancy-specific beta-1-glycoprotein 3 [PSG3], chorionic gonadotropin-alpha subunit, and pregnancy-associated plasma protein-A) biomarkers were able to predict a maximum sensitivity of 93.3% and a maximum specificity of 98.6%. The model with the highest accuracy was 97.4% (with 70.2% receiving classification). Models using an overlapping group of 3 (soluble fms-like tyrosine kinase-1, PSG3, and tissue factor pathway inhibitor 2) biomarkers achieved a maximum sensitivity of 98.5% and a maximum specificity of 95.3%. The model with the highest accuracy was 94.4% (with 65.6% receiving classification). When the models were used simultaneously, the conclusive classification increased to 72.7% with an accuracy of 95.9%. The predictive ability of the biomarkers in the random forest produced similar test characteristics when using 11 predictive biomarkers. CONCLUSION: We have demonstrated a pool of biomarkers from divergent biological pathways that can be used to classify individuals with potential early pregnancy loss. The biomarkers choriogonadotropin alpha, pregnancy-associated plasma protein-A, and PSG3 can be used to predict viability, and soluble fms-like tyrosine kinase-1, tissue factor pathway inhibitor 2, and PSG3 can be used to predict pregnancy location.
引用
- Barnhart KT, Bollig KJ, Senapati S, et al. Multiplexed serum biomarkers to discriminate nonviable and ectopic pregnancy. Fertil Steril. 2024. PMID: 38677710. doi:10.1016/j.fertnstert.2024.04.028
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。